These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32842610)

  • 21. Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients - Insight From the Fushimi AF Registry.
    Hamatani Y; Ogawa H; Uozumi R; Iguchi M; Yamashita Y; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Morita S; Akao M
    Circ J; 2015; 79(5):1009-17. PubMed ID: 25740669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of primary and secondary stroke prevention in patients with nonvalvular atrial fibrillation: Results from the RAFFINE registry.
    Yamashiro K; Tanaka R; Miyazaki S; Miyauchi K; Hayashi H; Nishizaki Y; Nojiri S; Suwa S; Sumiyosi M; Nakazato Y; Urabe T; Hattori N; Minamino T; Daida H
    J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106871. PubMed ID: 36356431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry.
    Wang Y; Ma CS; Du X; He L; Li J; Wang GH; Wen D; Dong JZ; Pan JH; Lip GYH
    BMC Cardiovasc Disord; 2019 Nov; 19(1):283. PubMed ID: 31810439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
    Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P
    Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
    Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M
    Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study.
    Nielsen PB; Melgaard L; Overvad TF; Jensen M; Larsen TB; Lip GYH;
    Stroke; 2022 Aug; 53(8):2559-2568. PubMed ID: 35414198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding as an outcome among patients with nonvalvular atrial fibrillation in a large managed care population.
    Deitelzweig SB; Pinsky B; Buysman E; Lacey M; Makenbaeva D; Wiederkehr D; Graham J
    Clin Ther; 2013 Oct; 35(10):1536-45.e1. PubMed ID: 24075151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation.
    Krittayaphong R; Kanjanarutjawiwat W; Wisaratapong T; Lip GYH
    Eur J Clin Invest; 2023 Feb; 53(2):e13886. PubMed ID: 36197442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non-valvular atrial fibrillation patients in England.
    Bakhai A; Petri H; Vahidnia F; Wolf C; Ding Y; Foskett N; Sculpher M
    J Eval Clin Pract; 2021 Feb; 27(1):119-133. PubMed ID: 32314853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Steinberg BA; Kim S; Thomas L; Fonarow GC; Hylek E; Ansell J; Go AS; Chang P; Kowey P; Gersh BJ; Mahaffey KW; Singer DE; Piccini JP; Peterson ED;
    Circulation; 2014 May; 129(20):2005-12. PubMed ID: 24682387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.
    Paciaroni M; Agnelli G; Falocci N; Caso V; Becattini C; Marcheselli S; Rueckert C; Pezzini A; Poli L; Padovani A; Csiba L; Szabó L; Sohn SI; Tassinari T; Abdul-Rahim AH; Michel P; Cordier M; Vanacker P; Remillard S; Alberti A; Venti M; Scoditti U; Denti L; Orlandi G; Chiti A; Gialdini G; Bovi P; Carletti M; Rigatelli A; Putaala J; Tatlisumak T; Masotti L; Lorenzini G; Tassi R; Guideri F; Martini G; Tsivgoulis G; Vadikolias K; Liantinioti C; Corea F; Del Sette M; Ageno W; De Lodovici ML; Bono G; Baldi A; D'Anna S; Sacco S; Carolei A; Tiseo C; Acciarresi M; D'Amore C; Imberti D; Zabzuni D; Doronin B; Volodina V; Consoli D; Galati F; Pieroni A; Toni D; Monaco S; Baronello MM; Barlinn K; Pallesen LP; Kepplinger J; Bodechtel U; Gerber J; Deleu D; Melikyan G; Ibrahim F; Akhtar N; Mosconi MG; Bubba V; Silvestri I; Lees KR
    Stroke; 2015 Aug; 46(8):2175-82. PubMed ID: 26130094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
    Steinberg BA; Kim S; Piccini JP; Fonarow GC; Lopes RD; Thomas L; Ezekowitz MD; Ansell J; Kowey P; Singer DE; Gersh B; Mahaffey KW; Hylek E; Go AS; Chang P; Peterson ED;
    Circulation; 2013 Aug; 128(7):721-8. PubMed ID: 23861512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation.
    Koga M; Yoshimura S; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Todo K; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Yagita Y; Kario K; Shiozawa M; Sato S; Yamagami H; Arihiro S; Toyoda K;
    Stroke; 2016 Oct; 47(10):2582-8. PubMed ID: 27531346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of hemodialysis patients with atrial fibrillation: The RAKUEN (Registry of atrial fibrillation in chronic kidney disease under hemodialysis from Niigata) study.
    Mitsuma W; Matsubara T; Hatada K; Imai S; Saito N; Shimada H; Miyazaki S
    J Cardiol; 2016 Aug; 68(2):148-55. PubMed ID: 26527113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.
    Minematsu K; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Miyamoto S; Murakawa Y; Takeichi M; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S
    Cerebrovasc Dis; 2019; 48(1-2):53-60. PubMed ID: 31578012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry.
    Jerjes-Sanchez C; Corbalan R; Barretto ACP; Luciardi HL; Allu J; Illingworth L; Pieper KS; Kayani G;
    Clin Cardiol; 2019 May; 42(5):553-560. PubMed ID: 30873623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R; Pearce LA
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparison of CAS risk model and CHA
    Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants.
    O UF; Chong TK; Wei Y; Paudel B; Giudici MC; Wong CW; Lei WK; Chen J; Wu W; Liu K
    Int J Cardiol Heart Vasc; 2022 Jun; 40():101009. PubMed ID: 35372665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.
    Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Ma CS; Zint K; Elsaesser A; Lu S; Bartels DB; Lip GYH;
    Am Heart J; 2018 Apr; 198():55-63. PubMed ID: 29653649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.